Suppr超能文献

免疫球蛋白G4相关性肾病:发病机制、诊断与治疗

Immunoglobulin G4-related kidney disease: Pathogenesis, diagnosis, and treatment.

作者信息

Zheng Ke, Teng Fei, Li Xue-Mei

机构信息

Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.

出版信息

Chronic Dis Transl Med. 2017 Jul 8;3(3):138-147. doi: 10.1016/j.cdtm.2017.05.003. eCollection 2017 Sep.

Abstract

Immunoglobulin G4-related disease (IgG4-RD) is a recently recognized clinical entity that often involves multiple organs; it is characterized by high levels of serum immunoglobulin G4 (IgG4), dense infiltration of IgG4+ cells, and storiform fibrosis. Cellular immunity, particularly T cell-mediated immunity, has been implicated in the pathogenesis of IgG4-RD. The most frequent renal manifestations of IgG4-RD are IgG4-related tubulointerstitial nephritis, membranous glomerulonephropathy (MGN), and obstructive nephropathy secondary to urinary tract obstruction due to IgG4-related retroperitoneal fibrosis, prostatitis, or ureter inflammation. Kidney function impairment can be acute or chronic. In IgG4-MGN, proteinuria can be in the nephrotic range. The diagnosis of IgG4-related kidney disease should not be based solely on serum IgG4 levels or the number of tissue-infiltrating IgG4+ plasma cells. Diagnosis should be based on specific histopathological findings, confirmed by tissue immunostaining and an appropriate clinical context. Steroid treatment is the first-line therapy. For relapsing or refractory cases, immunosuppressants could be combined with steroids. In hydronephrosis patients, appropriate immunosuppressive therapy could preclude the implantation of a double J ureteral catheter.

摘要

免疫球蛋白G4相关性疾病(IgG4-RD)是一种最近才被认识的临床实体,常累及多个器官;其特征为血清免疫球蛋白G4(IgG4)水平升高、IgG4+细胞密集浸润以及席纹状纤维化。细胞免疫,尤其是T细胞介导的免疫,已被认为与IgG4-RD的发病机制有关。IgG4-RD最常见的肾脏表现为IgG4相关性肾小管间质性肾炎、膜性肾小球肾病(MGN)以及由于IgG4相关性腹膜后纤维化、前列腺炎或输尿管炎导致尿路梗阻继发的梗阻性肾病。肾功能损害可为急性或慢性。在IgG4-MGN中,蛋白尿可为肾病范围。IgG4相关性肾病的诊断不应仅基于血清IgG4水平或组织浸润IgG4+浆细胞的数量。诊断应基于特定的组织病理学发现,并通过组织免疫染色和适当的临床背景加以证实。类固醇治疗是一线治疗方法。对于复发或难治性病例,免疫抑制剂可与类固醇联合使用。在肾积水患者中,适当的免疫抑制治疗可避免植入双J输尿管导管。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9190/5643773/b84955b428df/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验